目次

TABLE OF CONTENTS

1 INTRODUCTION?
1.1 OBJECTIVES OF THE STUDY?
1.2 MARKET DEFINITION?
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE?
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY?
1.5 LIMITATIONS?
1.6 STAKEHOLDERS?
1.7 SUMMARY OF CHANGES?

2 RESEARCH METHODOLOGY?
2.1 RESEARCH APPROACH?
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.1.3 MARKET DATA ESTIMATION & TRIANGULATION
2.2 MARKET ESTIMATION METHODOLOGY?
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST?
2.4 INSIGHTS FROM PRIMARIES?
2.5 RESEARCH ASSUMPTIONS?
2.6 RISK ASSESSMENT?

3 EXECUTIVE SUMMARY?

4 PREMIUM INSIGHTS?

5 MARKET OVERVIEW?
5.1 INTRODUCTION?
5.2 MARKET DYNAMICS?
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 TECHNOLOGY ANALYSIS?
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS?
5.5 SUPPLY/VALUE CHAIN ANALYSIS?
5.6 ECOSYSTEM/MARKET MAP?
5.7 PORTERS FIVE FORCES ANALYSIS?
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.4 BARGAINING POWER OF BUYERS
5.7.5 INTENSITY OF COMPETITION RIVALRY
5.8 REGULATORY LANDSCAPE?
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
5.9 PRICING ANALYSIS?
5.9.1 AVERAGE SELLING PRICES OF KEY PLAYERS, BY SOURCE
5.9.2 AVERAGE SELLING PRICE TREND
5.10 PIPELINE ANALYSIS?
5.11 KEY CONFERENCES & EVENTS IN 2022-2023?
5.12 KEY STAKEHOLDERS & BUYING CRITERIA?

6 REGENERATIVE MEDICINE MARKET, BY PRODUCT?
6.1 INTRODUCTION?
6.2 CELL THERAPY?
6.2.1 STEM CELL THERAPY
6.2.1.1 AUTOLOGOUS THERAPY
6.2.1.2 ALLOGENIC THERAPY
6.2.2 CORD BLOOD/PROGENITOR CELL THERAPIES
6.2.3 CELL-BASED IMMUNOTHERAPY PRODUCTS
6.3 GENE THERAPY?
6.4 TISSUE ENGINEERING?
6.4.1 SCAFFOLDS
6.4.1 HYDROGELS
6.4.1 COLLAGEN
6.4.1 OTHERS

7 REGENERATIVE MEDICINE MARKET, BY APPLICATION?
7.1 INTRODUCTION?
7.2 MUSCULOSKELETAL?
7.3 ONCOLOGY?
7.4 DERMATOLOGY & WOUND CARE?
7.5 CARDIOVASCULAR?
7.6 OPHTHALMOLOGY?
7.7 CELL TRANSPLANTATIONS?
7.8 OTHER APPLICATIONS?

8 REGENERATIVE MEDICINE MARKET, BY REGION?
8.1 INTRODUCTION?
8.2 NORTH AMERICA?
8.2.1 US
8.2.2 CANADA
8.3 EUROPE?
8.3.1 GERMANY
8.3.2 UK
8.3.3 FRANCE
8.3.4 ITALY
8.3.5 REST OF EUROPE
8.4 ASIA PACIFIC?
8.4.1 JAPAN
8.4.2 CHINA
8.4.3 AUSTRALIA
8.4.4 INDIA
8.4.5 REST OF ASIA PACIFIC
8.5 LATIN AMERICA?
8.6 MIDDLE EAST & AFRICA?

9 COMPETITIVE LANDSCAPE?
9.1 OVERVIEW?
9.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS (2020/2021)?
9.3 MARKET SHARE ANALYSIS (2021)?
9.4 COMPANY EVALUATION QUADRANT?
9.4.1 STARS
9.4.2 EMERGING LEADERS
9.4.3 PERVASIVE PLAYERS
9.4.4 PARTICIPANTS
9.4.5 COMPETITIVE BENCHMARKING
9.5 START-UP/SME EVALUATION QUADRANT?
9.5.1 PROGRESSIVE COMPANIES
9.5.2 STARTING BLOCKS
9.5.3 RESPONSIVE COMPANIES
9.5.4 DYNAMIC COMPANIES
9.6 COMPETITIVE SCENARIO?
9.6.1 PRODUCT LAUNCHES
9.6.2 DEALS
9.6.3 OTHER DEVELOPMENTS

10 COMPANY PROFILES?
* Company profiles of 25 players (Including MNC and local players) will be provided in this section. This section will include Business Overview, Products Offered, Recent Developments, MnM View. Kindly note that, the financial analysis might not be captured in case of unlisted companies

11 APPENDIX?
11.1 DISCUSSION GUIDE?
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL?
11.3 AVAILABLE CUSTOMIZATIONS?
11.4 RELATED REPORTS?
11.5 AUTHOR DETAILS?